Gunderson Dettmer has advised BrainChild Bio. BrainChild Bio, a clinical-stage biotechnology company, has announced the closure of a $116 million Series A financing round. The financing...
BrainChild Bio Raises $116 Million in Series A Financing
Amplitude Therapeutics and Lilly Announce Strategic RNA Vaccine Collaboration
Gunderson Dettmer has advised Amplitude Therapeutics. Amplitude Therapeutics has entered into a strategic research collaboration and licensing agreement with Eli Lilly and Company (Lilly) to develop...
Urban SDK Secures $65 Million Growth Investment from Riverwood Capital
Gunderson Dettmer has advised Urban SDK on the deal. Urban SDK, a provider of geospatial AI solutions for cities, states, and Departments of Transportation, has received...
May Mobility’s $105 million Series D Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented May Mobility in the transaction. May Mobility announced its $105 million Series D financing round, as part of its...